217 related articles for article (PubMed ID: 34628697)
1. Early and short-term intensive management after discharge for patients hospitalized with acute heart failure: a randomized study (ECAD-HF).
Logeart D; Berthelot E; Bihry N; Eschalier R; Salvat M; Garcon P; Eicher JC; Cohen A; Tartiere JM; Samadi A; Donal E; deGroote P; Mewton N; Mansencal N; Raphael P; Ghanem N; Seronde MF; Chavelas C; Rosamel Y; Beauvais F; Kevorkian JP; Diallo A; Vicaut E; Isnard R
Eur J Heart Fail; 2022 Jan; 24(1):219-226. PubMed ID: 34628697
[TBL] [Abstract][Full Text] [Related]
2. Impact of B-lines-guided intensive heart failure management on outcome of discharged heart failure patients with residual B-lines.
Zhu Y; Li N; Wu M; Peng Z; Huang H; Zhao W; Yi L; Liao M; Liu Z; Peng Y; Zhou Y; Lu J; Li G; Zeng J
ESC Heart Fail; 2022 Aug; 9(4):2713-2718. PubMed ID: 35595501
[TBL] [Abstract][Full Text] [Related]
3. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
Gheorghiade M; Böhm M; Greene SJ; Fonarow GC; Lewis EF; Zannad F; Solomon SD; Baschiera F; Botha J; Hua TA; Gimpelewicz CR; Jaumont X; Lesogor A; Maggioni AP;
JAMA; 2013 Mar; 309(11):1125-35. PubMed ID: 23478743
[TBL] [Abstract][Full Text] [Related]
4. Real-World Analysis of Guideline-Based Therapy After Hospitalization for Heart Failure.
Wirtz HS; Sheer R; Honarpour N; Casebeer AW; Simmons JD; Kurtz CE; Pasquale MK; Globe G
J Am Heart Assoc; 2020 Aug; 9(16):e015042. PubMed ID: 32805181
[TBL] [Abstract][Full Text] [Related]
5. Remote Dielectric Sensing Before and After Discharge in Patients With ADHF: The ReDS-SAFE HF Trial.
Alvarez-Garcia J; Lala A; Rivas-Lasarte M; De Rueda C; Brunjes D; Lozano-Jimenez S; Garcia-Sebastian C; Mitter S; Remior P; Jimenez-Blanco Bravo M; Del Prado S; Barghash M; González-Ferrer E; Ullman J; Cobo M; Segovia-Cubero J; Zamorano JL; Pinney SP; Mancini D
JACC Heart Fail; 2024 Apr; 12(4):695-706. PubMed ID: 38430084
[TBL] [Abstract][Full Text] [Related]
6. Association between class of foundational medication for heart failure and prognosis in heart failure with reduced/mildly reduced ejection fraction.
Ito M; Maeda D; Matsue Y; Shiraishi Y; Dotare T; Sunayama T; Nogi K; Takei M; Ueda T; Nogi M; Ishihara S; Nakada Y; Kawakami R; Kagiyama N; Kitai T; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Kida K; Okumura T; Nagatomo Y; Kohno T; Nakano S; Kohsaka S; Yoshikawa T; Saito Y; Minamino T
Sci Rep; 2022 Oct; 12(1):16611. PubMed ID: 36198895
[TBL] [Abstract][Full Text] [Related]
7. Policy-Driven Post-Acute Care Program Lowers Mortality Rate and Medical Expenditures After Hospitalization for Acute Heart Failure: A Nationwide Propensity Score-Matched Study.
Wang CH; Kao FY; Tsai SL; Lee CM
J Am Med Dir Assoc; 2023 Jul; 24(7):978-984.e4. PubMed ID: 37146642
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
[TBL] [Abstract][Full Text] [Related]
9. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial.
Mebazaa A; Davison B; Chioncel O; Cohen-Solal A; Diaz R; Filippatos G; Metra M; Ponikowski P; Sliwa K; Voors AA; Edwards C; Novosadova M; Takagi K; Damasceno A; Saidu H; Gayat E; Pang PS; Celutkiene J; Cotter G
Lancet; 2022 Dec; 400(10367):1938-1952. PubMed ID: 36356631
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid receptor antagonist initiation during admission is associated with improved outcomes irrespective of ejection fraction in patients with acute heart failure.
Beldhuis IE; Damman K; Pang PS; Greenberg B; Davison BA; Cotter G; Gimpelewicz C; Felker GM; Filippatos G; Teerlink JR; Metra M; Voors AA; Ter Maaten JM
Eur J Heart Fail; 2023 Sep; 25(9):1584-1592. PubMed ID: 37462255
[TBL] [Abstract][Full Text] [Related]
11. Safety, Tolerability and efficacy of Rapid Optimization, helped by NT-proBNP and GDF-15, of Heart Failure therapies (STRONG-HF): rationale and design for a multicentre, randomized, parallel-group study.
Kimmoun A; Cotter G; Davison B; Takagi K; Addad F; Celutkiene J; Chioncel O; Solal AC; Diaz R; Damasceno A; Duengen HD; Filippatos G; Goncalvesova E; Merai I; Metra M; Ponikowski P; Privalov D; Sliwa K; Sani MU; Voors AA; Shogenov Z; Mebazaa A
Eur J Heart Fail; 2019 Nov; 21(11):1459-1467. PubMed ID: 31423712
[TBL] [Abstract][Full Text] [Related]
12. Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.
Ezekowitz JA; Lee DS; Tu JV; Newman AM; McAlister FA
Am J Cardiol; 2008 Jul; 102(1):79-83. PubMed ID: 18572040
[TBL] [Abstract][Full Text] [Related]
13. Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta-blockers in patients hospitalized for acute heart failure.
Carubelli V; Lombardi C; Specchia C; Peveri G; Oriecuia C; Tomasoni D; Di Pasquale M; Inciardi R; Garrafa E; Metra M
ESC Heart Fail; 2021 Jun; 8(3):1944-1953. PubMed ID: 33660949
[TBL] [Abstract][Full Text] [Related]
14. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
[TBL] [Abstract][Full Text] [Related]
15. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
[TBL] [Abstract][Full Text] [Related]
16. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study.
Pascual-Figal D; Wachter R; Senni M; Bao W; Noè A; Schwende H; Butylin D; Prescott MF;
JACC Heart Fail; 2020 Oct; 8(10):822-833. PubMed ID: 32800508
[TBL] [Abstract][Full Text] [Related]
17. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.
Berger R; Moertl D; Peter S; Ahmadi R; Huelsmann M; Yamuti S; Wagner B; Pacher R
J Am Coll Cardiol; 2010 Feb; 55(7):645-53. PubMed ID: 20170790
[TBL] [Abstract][Full Text] [Related]
18. Risk prediction for 30-day heart failure-specific readmission or death after discharge: Data from the Korean Acute Heart Failure (KorAHF) registry.
Lim NK; Lee SE; Lee HY; Cho HJ; Choe WS; Kim H; Choi JO; Jeon ES; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Cho MC; Oh BH; Park HY
J Cardiol; 2019 Feb; 73(2):108-113. PubMed ID: 30360893
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
Ehteshami-Afshar S; Mooney L; Dewan P; Desai AS; Lang NN; Lefkowitz MP; Petrie MC; Rizkala AR; Rouleau JL; Solomon SD; Swedberg K; Shi VC; Zile MR; Packer M; McMurray JJV; Jhund PS; Hawkins NM
J Am Heart Assoc; 2021 Feb; 10(4):e019238. PubMed ID: 33522249
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of a personalized algorithm-based discharge checklist in patients hospitalized for acute heart failure.
Allain F; Loizeau V; Chaufourier L; Hallouche M; Herrou L; Hodzic A; Blanchart K; Belin A; Manrique A; Milliez P; Sabatier R; Legallois D
ESC Heart Fail; 2020 Jun; 7(3):1217-1223. PubMed ID: 32320135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
